Assessment of strategies for identifying diagnosed cases of systemic lupus erythematosus through self-report

Lupus

Volumn 12, Issue 10, 2003, Pages 754-759

  McAlindon, Timothy E ^a   Formica, M ^a   Palmer, J R ^b   Lafyatis, R ^c   Rosenberg, L ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Case confirmation; Classification; Epidemiology; Lupus; SLE

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISONE;

ADULT; ALGORITHM; ARTICLE; DISEASE CLASSIFICATION; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MEDICAL RECORD; NEGRO; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ALGORITHMS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEDICAL RECORDS; PHYSICIANS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES;

EID: 0142119144     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu460oa     Document Type: Article

References (12)

1. Kehoe R, Wu SY, Leske MC, Chylack LT Jr. Comparing self-reported and physician-reported medical history. Am J Epidemiol 1994; 139(8): 813-818.
2. Colditz GA, Martin P, Stampfer MJ et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986; 123(5): 894-900.
3. Rasooly I, Papageorgiou AC, Badley EM. Comparison of clinical and self reported diagnosis for rheumatology outpatients. Ann Rheum Dis 1995; 54(10): 850-852.
4. Lahita RG. Special report: adjusted lupus prevalence. Results of a marketing study by the Lupus Foundation of America. Lupus 1995; 4(6): 450-453.
5. Rosenberg L, Palmer JR, Rao RS, Adams-Campbell LL. Risk factors for coronary heart disease in African American women. Am J Epidemiol 1999; 150(9): 904-909.
6. Liang MH, Meenan RF, Cathcart ES, Schur PH. A screening strategy for population studies in systemic lupus erythematosus. Series design. Arthritis Rheum 1980; 23(2): 153-157.
7. Hochberg MC, Schmidt MC, Funk KL, Sutton JD, Stevens MB. Validity and yield of a two-stage screening procedure for systemic lupus erythematosus. Clin Exp Rheumatol 1983; 1(1): 67-71.
8. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter] [see comments]. Arthritis Rheum 1997; 40(9): 1725.
9. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25(11): 1271-1277.
10. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995; 38(4): 551-558.
11. McAlindon T, Toma W, Ruddock V, Meenan R, Ginzler E. Further development of the lupus screening questionnaire (LSQ) in black women. Arthritis Rheum 1997; 40(9 suppl): 490.
12. Karlson EW, Lee I, Cook NR, Manson JE, Buring JE, Hennekens CH. Comparison of self-reported diagnosis of connective tissue disease with medical records in female health professionals. Am J Epidemiol 1999; 150: 652-660.